Current Pharmacogenomics and Personalized Medicine
Title: Editorial [Revisiting the Paris Declaration: Pharmacogenomics and Personalized Medicine as Accelerators for Development Aid and Effectiveness]
Volume: 9 Issue: 4
Author(s): Alexander Borda-Rodriguez and Farah Huzair
Affiliation:
Keywords: Aid Effectiveness, Millennium Development Goals, Paris Declaration, partnerships, personalized medicine, pharmacogenomics
Export Options
About this article
Cite this article as:
Borda-Rodriguez Alexander and Huzair Farah, Editorial [Revisiting the Paris Declaration: Pharmacogenomics and Personalized Medicine as Accelerators for Development Aid and Effectiveness], Current Pharmacogenomics and Personalized Medicine 2011; 9 (4) . https://dx.doi.org/10.2174/187569211798377162
DOI https://dx.doi.org/10.2174/187569211798377162 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis
Current Pharmaceutical Biotechnology Microemulsion and Microemulsion-Based Gels for Topical Antifungal Therapy with Phytochemicals
Current Pharmaceutical Design Nitric Oxide, Epileptic Seizures, and Action of Antiepileptic Drugs
CNS & Neurological Disorders - Drug Targets Uropathogenic Escherichia coli Mediated Urinary Tract Infection
Current Drug Targets Elevated Levels of Bilirubin and Long-Term Exposure Impair Human Brain Microvascular Endothelial Cell Integrity
Current Neurovascular Research Clearance of Beta-Amyloid in the Brain
Current Medicinal Chemistry Embryonic Stem Cell-Based Screen for Small Molecules: Cluster Analysis Reveals Four Response Patterns in Developing Neural Cells
Current Medicinal Chemistry Coumarins as Inhibitors of HIV Reverse Transcriptase
Current HIV Research 3D Synthetic Brain MRI with Compressed Sensing: Can It be a Promising way Forward for Daily Neuroimaging?
Current Medical Imaging Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry Protein and Antibody Engineering: Suppressing Degranulation of the Mast Cells and Type I Hypersensitivity Reaction
Current Protein & Peptide Science The Premature Lottery in the Canadian Grey Zones
Current Pediatric Reviews Serratia, No Longer an Uncommon Opportunistic Pathogen – Case Series & Review of Literature
Infectious Disorders - Drug Targets Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System
Current Medicinal Chemistry Targeting to 5-HT1F Receptor Subtype for Migraine Treatment: Lessons from the Past, Implications for the Future
Central Nervous System Agents in Medicinal Chemistry Reversible Intracranial Cytotoxic Edema Associated with COVID-19: A Case Report
Current Medical Imaging Mast Cells as a Double Edged Sword in Immunity: Disorders of Mast Cell Activation and Therapeutic Management. Second of Two Parts
Endocrine, Metabolic & Immune Disorders - Drug Targets Mast Cells: Target and Source of Neuropeptides
Current Pharmaceutical Design Community-Acquired Pneumonia in Children
Recent Patents on Inflammation & Allergy Drug Discovery An Update on the Synthesis and Antibacterial Effects of Carbapenems
Recent Patents on Anti-Infective Drug Discovery